Enhancement of the alpha receptor blocking action of N-ethoxycarbonyl-2--ethoxy-1,2-dihydroquinoline (EEDQ) by amines.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001011:Aorta; D001158:Arteries / Q000187:drug effects*; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011817:Rabbits; D012701:Serotonin / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D013565:Sympatholytics; D013566:Sympathomimetics; D010656:Phenylephrine; D012701:Serotonin; D006632:Histamine; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine